Medical Imaging Phantoms Market Size, Share, Growth, and Industry Analysis, By Type (X-ray/Fluoroscopy Phantoms,Ultrasound Phantoms,CT Phantoms,MRI Phantoms,Nuclear Imaging Phantoms,Others), By Application (Hospitals,Medical Device Companies,Academic & Research Institutes,Diagnostic & Reference Laboratories,Others), Regional Insights and Forecast to 2035

Medical Imaging Phantoms Market Overview

The global Medical Imaging Phantoms Market size is projected to grow from USD 206.34 million in 2026 to USD 216.19 million in 2027, reaching USD 313.85 million by 2035, expanding at a CAGR of 4.77% during the forecast period.

The Medical Imaging Phantoms Market is rapidly expanding with strong adoption in radiology, oncology, cardiology, and diagnostic imaging centers. More than 62% of hospitals worldwide utilize medical imaging phantoms for quality assurance testing of CT, MRI, ultrasound, and PET systems. Annually, over 1.8 million imaging phantoms are used for calibration and research globally, ensuring accurate image reproduction. North America leads with 38% of market share, followed by Europe at 29% and Asia-Pacific at 24%. Increasing demand for high-quality imaging and training in over 70,000 diagnostic centers worldwide drives consistent growth in the medical imaging phantoms industry.

In the USA, the Medical Imaging Phantoms Market accounts for nearly 21% of global demand. More than 450,000 imaging phantoms are used annually across hospitals, academic centers, and diagnostic labs. Around 47% of radiology departments in the USA employ MRI phantoms for calibration, while 36% of institutions rely on CT phantoms to enhance accuracy in cancer detection. The USA also leads in academic use, with over 3,500 medical schools and training facilities integrating imaging phantoms into educat

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: Around 68% demand is driven by rising adoption of imaging phantoms in CT, MRI, and PET quality control applications globally.
• Major Market Restraint: Nearly 41% restraints are linked to high product costs and limited accessibility in low-resource healthcare settings worldwide.
• Emerging Trends: Over 34% of new developments focus on advanced 3D-printed phantoms for oncology, cardiology, and neurological imaging applications.
• Regional Leadership: North America dominates with 38% share of global medical imaging phantoms demand, followed by Europe at 29% and Asia-Pacific at 24%.
• Competitive Landscape: Top 10 manufacturers hold 52% of global share, with leading companies introducing 27% more product innovations between 2022 and 2024.
• Market Segmentation: Nearly 46% of demand comes from hospitals, 32% from diagnostic centers, and 22% from academic and research institutes worldwide.
• Recent Development: Over 29% of new product launches between 2023 and 2025 are focused on AI-integrated imaging phantom solutions for smart calibration systems.

Medical Imaging Phantoms Market Latest Trends

The Medical Imaging Phantoms Market is evolving with advanced material innovations, digital integration, and specialized designs for disease-specific training. More than 620,000 CT imaging phantoms are produced annually, with 39% of them used in oncology applications. MRI phantoms represent another fast-growing category, with nearly 500,000 units deployed globally to standardize imaging quality. The emergence of 3D-printed phantoms has surged by 28% in the last three years, providing more realistic anatomical structures for radiology training and research. 

Medical Imaging Phantoms Market Dynamics

DRIVER

"Rising demand for diagnostic imaging accuracy"

The primary driver of the Medical Imaging Phantoms Market is the rising global demand for diagnostic imaging accuracy. More than 3.6 billion diagnostic imaging procedures are performed worldwide annually, and over 67% require quality control through phantoms. In oncology, where 19 million new cancer cases were reported in 2022, more than 52% of diagnostic centers use CT phantoms for early detection. 

RESTRAINT

"High cost of advanced imaging phantoms"

One of the major restraints of the Medical Imaging Phantoms Market is the high cost of advanced phantom products. Nearly 41% of small and medium diagnostic centers in low- and middle-income countries struggle with affordability. High-precision MRI phantoms can cost 2 to 3 times more than ultrasound phantoms, limiting widespread adoption. In Africa, only 22% of diagnostic laboratories have access to phantoms for calibration, compared to 71% in Europe. 

OPPORTUNITY

"Expansion of 3D printing and AI integration"

3D printing and artificial intelligence are creating new opportunities in the Medical Imaging Phantoms Market. More than 29% of recent investments from manufacturers focus on 3D-printed phantoms that replicate real anatomical structures for training and research. Between 2021 and 2023, over 1,200 hospitals adopted AI-based calibration systems using smart phantoms, improving accuracy by 26%. In cardiology, 3D-printed heart phantoms are used in more than 410 global research programs for testing imaging technologies.

CHALLENGE

"Shortage of skilled professionals for phantom usage"

A major challenge for the Medical Imaging Phantoms Market is the shortage of skilled professionals capable of effectively using phantoms for calibration and training. Globally, only 42% of radiology professionals are trained in phantom-based quality assurance procedures. In Asia-Pacific, where demand is growing fastest, only 38% of hospitals have specialized phantom technicians. 

Medical Imaging Phantoms Market Segmentation 

The Medical Imaging Phantoms Market is segmented by type and application, showing diverse usage across diagnostic imaging modalities and healthcare institutions. By type, the market is divided into X-ray/Fluoroscopy Phantoms, Ultrasound Phantoms, CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, and Others. By application, it is segmented into Hospitals, Medical Device Companies, Academic & Research Institutes, Diagnostic & Reference Laboratories, and Others. 

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

X-ray/Fluoroscopy Phantoms: X-ray/Fluoroscopy phantoms are widely used for radiation dose measurement and image quality evaluation, making up 21% of the global market. More than 370,000 phantoms are in use worldwide, supporting accurate diagnostics in oncology and orthopedics. 

X-ray/Fluoroscopy Phantoms Market Size is 370,000 units globally, with 21% share and CAGR of 4.8%, mainly supporting oncology, orthopedics, and radiation dose evaluation across diagnostic centers worldwide.

Top 5 Major Dominant Countries in the X-ray/Fluoroscopy Phantom Segment

• The United States consumes 120,000 units, 7% share and CAGR of 4.7%, driven by cancer screening and orthopedic diagnostic centers nationwide.
• China records 90,000 units, 5% share and CAGR of 5.2%, supported by rising hospital infrastructure and radiology expansion programs nationwide.
• Germany uses 55,000 units, 3% share and CAGR of 4.3%, with demand from oncology and orthopedic diagnostic centers across major cities.
• India consumes 48,000 units, 2% share and CAGR of 5.6%, supported by diagnostic expansion and rising cancer incidence rates.
• Japan records 40,000 units, 2% share and CAGR of 3.9%, driven by orthopedic and oncological imaging needs nationwide.

Ultrasound Phantoms: Ultrasound phantoms hold 19% of the global market, with over 340,000 units consumed annually for training, calibration, and research purposes. Around 52% of medical schools worldwide use ultrasound phantoms for educational programs in obstetrics, gynecology, and cardiology. 

Ultrasound Phantoms Market Size is 340,000 units globally, with 19% share and CAGR of 5.0%, mainly supporting obstetrics, cardiology, and simulation-based training applications worldwide.

Top 5 Major Dominant Countries in the Ultrasound Phantom Segment

• The United States records 110,000 units, 6% share and CAGR of 4.8%, supported by strong cardiology and obstetrics training programs nationwide.
• China consumes 85,000 units, 5% share and CAGR of 5.4%, driven by rising ultrasound adoption in maternal care programs.
• India uses 50,000 units, 3% share and CAGR of 5.9%, mainly for simulation-based medical school programs and diagnostic labs.
• Japan records 45,000 units, 2% share and CAGR of 4.0%, with demand from cardiology and gynecology centers nationwide.
• Germany consumes 40,000 units, 2% share and CAGR of 3.7%, with demand from advanced ultrasound labs in hospitals nationwide.

CT Phantoms: CT phantoms account for 18% of the market, with annual usage of 320,000 units globally. More than 62% of oncology centers employ CT phantoms to enhance accuracy in tumor imaging and treatment planning. Around 47% of diagnostic labs worldwide integrate CT phantoms for calibration. 

CT Phantoms Market Size is 320,000 units globally, with 18% share and CAGR of 5.3%, largely used in oncology and diagnostic calibration processes worldwide.

Top 5 Major Dominant Countries in the CT Phantom Segment

• The United States consumes 105,000 units, 6% share and CAGR of 5.0%, mainly driven by oncology imaging centers and diagnostic labs nationwide.
• China records 78,000 units, 5% share and CAGR of 5.6%, supported by cancer detection and CT calibration in hospitals nationwide.
• India uses 42,000 units, 2% share and CAGR of 5.8%, fueled by oncology diagnostic expansion across metropolitan areas.
• Germany records 38,000 units, 2% share and CAGR of 4.2%, with demand from advanced imaging labs and cancer centers nationwide.
• Japan consumes 35,000 units, 2% share and CAGR of 3.9%, supported by tumor detection and neurological imaging demand nationwide.

MRI Phantoms: MRI phantoms represent 20% of the total market, with global annual usage of 360,000 units. Around 43% of neurology labs employ MRI phantoms for calibration in Alzheimer’s and Parkinson’s disease detection. Hospitals worldwide consume 57% of MRI phantoms for brain and spine imaging, while 28% are used in cardiology.

MRI Phantoms Market Size is 360,000 units globally, with 20% share and CAGR of 5.4%, primarily supporting neurology, oncology, and cardiology imaging calibration worldwide.

Top 5 Major Dominant Countries in the MRI Phantom Segment

• The United States consumes 115,000 units, 7% share and CAGR of 5.1%, mainly in neurology, spine imaging, and oncology nationwide.
• China records 82,000 units, 5% share and CAGR of 5.7%, supported by expansion of neurological imaging labs nationwide.
• Japan uses 55,000 units, 3% share and CAGR of 3.9%, driven by cardiology and neurology phantom calibration nationwide.
• Germany records 48,000 units, 2% share and CAGR of 4.4%, with demand from hospitals and training centers nationwide.
• India consumes 44,000 units, 2% share and CAGR of 5.8%, mainly for neurology and oncology diagnostics nationwide.

Nuclear Imaging Phantoms: Nuclear imaging phantoms account for 12% of the market, with 220,000 units used annually. Around 61% of nuclear medicine labs employ these phantoms to ensure accuracy in PET and SPECT scans. With more than 11 million PET scans performed globally each year, phantoms are critical in calibrating radiation dose and ensuring patient safety. 

Nuclear Imaging Phantoms Market Size is 220,000 units globally, with 12% share and CAGR of 4.9%, supporting PET and SPECT calibration processes worldwide.

Top 5 Major Dominant Countries in the Nuclear Imaging Phantom Segment

• The United States consumes 72,000 units, 4% share and CAGR of 4.6%, with demand from oncology and nuclear imaging centers nationwide.
• China records 50,000 units, 3% share and CAGR of 5.1%, driven by precision cancer diagnostics in nuclear medicine centers.
• India uses 32,000 units, 2% share and CAGR of 5.5%, mainly for PET scan calibration across urban hospitals.
• Germany records 34,000 units, 2% share and CAGR of 4.2%, with demand from advanced nuclear medicine labs nationwide.
• Japan consumes 32,000 units, 2% share and CAGR of 3.9%, supported by oncology imaging and nuclear diagnostic centers nationwide.

Others: The "Others" category includes hybrid, digital, and 3D-printed phantoms, representing 10% of demand with 180,000 units consumed annually. Around 27% of new phantom developments between 2022 and 2024 were 3D-printed models, reflecting growing adoption in training and calibration. These phantoms are widely used in simulation labs, accounting for 19% of educational use worldwide.

Others Segment Market Size is 180,000 units globally, with 10% share and CAGR of 5.2%, steadily expanding in hybrid, 3D-printed, and digital phantom applications worldwide.

Top 5 Major Dominant Countries in the Others Segment

• The United States records 62,000 units, 3% share and CAGR of 5.0%, mainly in simulation and training labs nationwide.
• China consumes 48,000 units, 3% share and CAGR of 5.5%, strongly driven by 3D-printed phantom adoption across hospitals.
• India records 26,000 units, 1% share and CAGR of 5.9%, mainly for simulation-based medical school education.
• Japan uses 24,000 units, 1% share and CAGR of 3.8%, with demand from advanced hybrid phantom projects.
• Germany consumes 20,000 units, 1% share and CAGR of 4.1%, mainly for simulation labs in academic institutes.

BY APPLICATION

Hospitals: Hospitals represent the largest application, consuming 830,000 phantoms annually, accounting for 46% of global demand. More than 58% of hospitals worldwide use phantoms for quality control, calibration, and staff training. Oncology, neurology, and cardiology departments are the primary users, with strong demand in large healthcare facilities. Around 42% of phantoms in hospitals are dedicated to CT and MRI calibration. With over 12,000 hospitals globally expanding radiology infrastructure, adoption continues to rise significantly across regions.

Hospitals Application Market Size is 830,000 units globally, holding 46% share and CAGR of 5.3%, strongly driven by oncology, neurology, and radiology department usage worldwide.

Top 5 Major Dominant Countries in the Hospitals Application Segment

• The United States consumes 260,000 units, 14% share and CAGR of 5.0%, primarily in oncology and radiology departments nationwide.
• China records 220,000 units, 12% share and CAGR of 5.4%, driven by hospital expansion and cancer detection programs.
• India uses 110,000 units, 6% share and CAGR of 5.7%, strongly supported by hospital oncology expansion programs nationwide.
• Germany records 95,000 units, 5% share and CAGR of 4.3%, mainly from radiology departments in urban hospitals.
• Japan consumes 85,000 units, 5% share and CAGR of 3.9%, primarily in neurological and oncology imaging departments nationwide.

Medical Device Companies: Medical device companies account for 340,000 units annually, representing 19% of demand. Around 48% of phantom consumption in this segment is for product testing, device calibration, and R&D purposes. More than 620 companies worldwide use phantoms in clinical validation programs. The growth of AI-integrated medical devices has further increased demand for advanced phantoms. With strong demand from imaging equipment manufacturers, medical device companies remain a critical application area.

Medical Device Companies Application Market Size is 340,000 units globally, with 19% share and CAGR of 4.9%, focused on calibration, R&D, and device testing globally.

Top 5 Major Dominant Countries in the Medical Device Companies Application Segment

• The United States consumes 110,000 units, 6% share and CAGR of 4.7%, mainly for R&D programs by imaging equipment manufacturers nationwide.
• China records 85,000 units, 5% share and CAGR of 5.3%, driven by medical device R&D companies nationwide.
• Germany uses 55,000 units, 3% share and CAGR of 4.2%, strongly applied in R&D programs across Europe.
• India consumes 45,000 units, 2% share and CAGR of 5.6%, mainly for calibration and clinical validation programs.
• Japan records 45,000 units, 2% share and CAGR of 3.9%, supported by medical device calibration projects nationwide.

Academic & Research Institutes: Academic and research institutes use 280,000 phantoms annually, contributing 15% of global demand. More than 52% of medical schools integrate phantoms into radiology training. Around 39% of usage in this segment is focused on MRI and CT teaching models. Over 16,000 academic centers globally have adopted phantoms for teaching, calibration, and simulation-based training programs. With increasing emphasis on practical training, demand in this segment continues to expand steadily.

Academic & Research Institutes Application Market Size is 280,000 units globally, with 15% share and CAGR of 5.2%, primarily supporting simulation-based training and radiology education worldwide.

Top 5 Major Dominant Countries in the Academic & Research Institutes Application Segment

• The United States records 95,000 units, 5% share and CAGR of 4.9%, with usage in medical schools and research centers nationwide.
• China consumes 75,000 units, 4% share and CAGR of 5.5%, focused on simulation and medical education programs nationwide.
• India uses 48,000 units, 3% share and CAGR of 5.9%, mainly for simulation training in academic centers nationwide.
• Germany records 35,000 units, 2% share and CAGR of 4.1%, strongly applied in academic training institutions nationwide.
• Japan consumes 27,000 units, 1% share and CAGR of 3.8%, primarily for academic radiology programs nationwide.

Diagnostic & Reference Laboratories: Diagnostic and reference laboratories account for 240,000 units annually, representing 13% of demand. Around 61% of usage in this segment is dedicated to CT and MRI calibration. Laboratories worldwide rely on phantoms to improve diagnostic accuracy, with more than 25,000 labs adopting them in routine testing. 

Diagnostic & Reference Laboratories Application Market Size is 240,000 units globally, with 13% share and CAGR of 5.1%, mainly used for calibration and diagnostic accuracy worldwide.

Top 5 Major Dominant Countries in the Diagnostic & Reference Laboratories Application Segment

• The United States consumes 82,000 units, 5% share and CAGR of 4.6%, mainly for CT and MRI calibration nationwide.
• China records 60,000 units, 3% share and CAGR of 5.2%, largely for cancer and neurology lab diagnostics nationwide.
• India uses 38,000 units, 2% share and CAGR of 5.7%, mainly for diagnostic calibration programs nationwide.
• Germany consumes 32,000 units, 2% share and CAGR of 4.1%, supported by diagnostic laboratory quality control programs nationwide.
• Japan records 28,000 units, 1% share and CAGR of 3.9%, focused on MRI and CT calibration in diagnostic labs nationwide.

Others: The "Others" category includes simulation centers, military medical training, and telemedicine programs, representing 110,000 units annually, or 7% of global demand. Around 28% of military medical training centers globally employ phantoms for battlefield simulation training. 

Others Application Market Size is 110,000 units globally, with 7% share and CAGR of 4.8%, primarily supporting simulation centers and telemedicine applications worldwide.

Top 5 Major Dominant Countries in the Others Application Segment

• The United States consumes 40,000 units, 2% share and CAGR of 4.7%, mainly for simulation training and telemedicine programs nationwide.
• China records 28,000 units, 2% share and CAGR of 5.1%, focused on digital healthcare simulation programs nationwide.
• India uses 18,000 units, 1% share and CAGR of 5.5%, mainly for military and academic simulation programs.
• Germany consumes 14,000 units, 0.8% share and CAGR of 4.0%, largely for telemedicine platforms and simulation labs nationwide.
• Japan records 10,000 units, 0.6% share and CAGR of 3.7%, primarily for digital learning and simulation-based applications nationwide.

Medical Imaging Phantoms Market Regional Outlook

North America: The region holds strong dominance with the USA, Canada, and Mexico showing high adoption rates of CT, MRI, and ultrasound phantoms. More than 38% of global phantom demand comes from North America.Europe: Advanced healthcare systems in Germany, France, the UK, and Italy drive phantom adoption. Europe accounts for 29% of global share, supported by strong hospital infrastructure and academic integration of phantoms.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America represents 38% of global Medical Imaging Phantoms Market consumption, totaling more than 680,000 units annually. The USA accounts for 61% of regional demand, followed by Canada with 21% and Mexico with 12%. More than 54% of hospitals in North America integrate CT and MRI phantoms for oncology, neurology, and cardiology diagnostics. 

North America Market Size stands at 680,000 units, holding 38% share and CAGR of 5.0%, strongly supported by advanced healthcare infrastructure, high imaging procedure volumes, and training adoption across universities.

North America - Major Dominant Countrie

• The United States consumes 415,000 units, 23% global share and CAGR of 5.1%, supported by strong oncology and neurology imaging programs across 6,200 diagnostic centers.
• Canada records 145,000 units, 8% share and CAGR of 4.7%, mainly driven by academic training centers and oncology hospitals nationwide.
• Mexico consumes 82,000 units, 5% share and CAGR of 4.9%, with demand from urban hospitals and diagnostic labs nationwide.
• Puerto Rico uses 20,000 units, 1% share and CAGR of 3.8%, primarily for hospital imaging calibration and training programs.
• Cuba records 18,000 units, 1% share and CAGR of 3.9%, supported by oncology diagnostic expansions nationwide.

EUROPE

Europe accounts for 29% of global Medical Imaging Phantoms demand, totaling over 520,000 units annually. Germany and France lead with a combined 38% of European demand, followed by the UK and Italy. Around 63% of European hospitals use phantoms for CT and MRI calibration, ensuring quality in oncology and neurology diagnostics. 

Europe Market Size is 520,000 units, with 29% share and CAGR of 4.6%, driven by advanced hospitals, oncology centers, and strong integration in academic training institutions.

Europe - Major Dominant Countries

• Germany consumes 140,000 units, 8% share and CAGR of 4.5%, supported by oncology hospitals and radiology training centers nationwide.
• France records 120,000 units, 7% share and CAGR of 4.4%, mainly from hospitals and diagnostic labs focusing on oncology imaging.
• The United Kingdom uses 105,000 units, 6% share and CAGR of 4.3%, strongly from MRI and ultrasound phantoms in hospitals.
• Italy consumes 85,000 units, 5% share and CAGR of 4.1%, driven by diagnostic and academic training adoption nationwide.
• Spain records 70,000 units, 4% share and CAGR of 4.0%, with usage in hospitals and diagnostic centers nationwide.

ASIA-PACIFIC

Asia-Pacific represents 24% of the Medical Imaging Phantoms Market, consuming 430,000 units annually. China leads with 42% of regional demand, followed by India with 26% and Japan with 18%. Around 72% of regional hospitals use CT and MRI phantoms for oncology and neurological imaging. Asia-Pacific is the fastest-growing region, with phantom adoption increasing by 19% in the last three years. 

Asia-Pacific Market Size totals 430,000 units, holding 24% share and CAGR of 6.0%, driven by oncology, cardiology, and academic training adoption across emerging and developed economies.

Asia - Major Dominant Countries 

• China consumes 180,000 units, 10% share and CAGR of 6.3%, driven by hospital and diagnostic expansion nationwide.
• India records 112,000 units, 6% share and CAGR of 6.5%, strongly from oncology and academic training facilities nationwide.
• Japan uses 78,000 units, 4% share and CAGR of 3.9%, mainly for neurology and cardiology imaging calibration nationwide.
• South Korea consumes 35,000 units, 2% share and CAGR of 4.2%, supported by advanced hospital imaging labs nationwide.
• Indonesia records 25,000 units, 1% share and CAGR of 5.6%, driven by diagnostic and hospital expansions nationwide.

MIDDLE EAST & AFRICA

Middle East & Africa contributes 9% of global Medical Imaging Phantoms Market demand, with 160,000 units consumed annually. Saudi Arabia and the UAE together account for 43% of the region’s demand, followed by South Africa at 19%. Around 61% of hospitals in the region use phantoms for CT, MRI, and ultrasound calibration, mainly in oncology and neurology imaging. 

Middle East & Africa Market Size stands at 160,000 units, with 9% share and CAGR of 5.2%, supported by mega-hospital projects, diagnostic expansions, and academic training adoption across leading countries.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia consumes 45,000 units, 2% share and CAGR of 5.6%, supported by mega-hospital projects and diagnostic labs.
• United Arab Emirates records 24,000 units, 1% share and CAGR of 5.1%, mainly from oncology hospitals and advanced training centers.
• South Africa uses 30,000 units, 2% share and CAGR of 4.7%, primarily for hospital diagnostic imaging calibration nationwide.
• Egypt consumes 28,000 units, 1% share and CAGR of 5.0%, strongly driven by diagnostic and academic usage nationwide.
• Nigeria records 22,000 units, 1% share and CAGR of 4.8%, mainly for diagnostic labs and oncology hospitals nationwide.

List of Top Medical Imaging Phantoms Market Companies

• Pure Imaging Phantoms
• Modus Medical Devices
• PTW Freiburg
• Carville Limited
• Gold Standard Phantoms
• Kyoto Kagaku
• Computerized Imaging Reference Systems (CIRS)
• Dielectric Corporation
• Biodex Medical Systems
• Leeds Test Objects

Top Two companies with highest share

• Modus Medical Devices: Modus Medical Devices leads with 11% global share, producing over 200,000 units annually across MRI and CT phantoms, widely used in hospitals and diagnostic centers worldwide.
• Computerized Imaging Reference Systems (CIRS): CIRS holds 9% share, producing more than 160,000 units annually, strongly adopted in oncology imaging and academic radiology training centers across 50 countries.

Investment Analysis and Opportunities

Investments in the Medical Imaging Phantoms Market are driven by demand for diagnostic accuracy and training. Between 2021 and 2023, over 1.1 billion USD was invested globally in phantom-based imaging projects, with 61% of funds directed toward MRI and CT calibration. More than 3,200 hospitals globally upgraded phantom-based QA systems in the past three years. Opportunities lie in AI-based calibration devices, with 19% growth in adoption since 2020. Emerging markets such as India and Brazil show 28% higher growth in phantom investments, especially for oncology centers. Additionally, 3D-printed phantoms represent 22% of new investments, highlighting innovation-driven opportunities.

New Product Development

New product development in the Medical Imaging Phantoms Market focuses on advanced materials, 3D printing, and AI integration. Between 2022 and 2024, more than 31% of new launches were 3D-printed phantoms, enabling realistic anatomical structures for education. MRI phantoms with smart calibration sensors now represent 24% of innovations. AI-based phantom solutions grew by 17% in the last two years, reducing calibration time by 28%. Companies like Kyoto Kagaku and Modus Medical Devices introduced hybrid digital-physical phantoms in 2024, already adopted by 1,200 hospitals. These innovations are reshaping the market, enabling broader use in training and diagnostics worldwide.

Five Recent Developments 

• In 2023, Modus Medical Devices launched AI-integrated MRI phantoms adopted by 600 hospitals worldwide for advanced calibration and imaging accuracy.
• In 2024, CIRS expanded production capacity by 120,000 units in the USA to meet growing oncology imaging phantom demand.
• In 2024, Kyoto Kagaku introduced 3D-printed cardiology phantoms, already adopted in 380 medical schools across Asia and Europe.
• In 2025, PTW Freiburg announced digital radiation phantoms, used in 210 hospitals across Europe for oncology diagnostics.
• In 2025, Gold Standard Phantoms launched neurological imaging phantoms, covering Alzheimer’s and Parkinson’s diagnostics, deployed in 150 hospitals worldwide.

Report Coverage of Medical Imaging Phantoms Market

The Medical Imaging Phantoms Market report covers a detailed assessment of market segmentation, regional outlook, competitive landscape, key investments, and new product developments. It analyzes demand across more than 90 countries, representing 1.8 million units consumed annually. The report includes segmentation by type, highlighting CT, MRI, ultrasound, X-ray, and nuclear imaging phantoms, which together account for 90% of global demand. It also analyzes applications, showing 46% demand from hospitals, 32% from diagnostic centers, and 22% from academic institutions. The regional outlook section covers North America with 38% share, Europe with 29%, Asia-Pacific with 24%, and Middle East & Africa with 9%. Competitive analysis shows top 10 companies controlling 54% of the global market. Emerging opportunities such as AI integration, 3D-printed phantoms, and oncology-specific solutions are identified as growth drivers. The report provides strategic insights for stakeholders, covering innovations, investments, and global adoption patterns across the healthcare and diagnostic imaging ecosystem.

Medical Imaging Phantoms Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 206.34 Million in 2026
Market Size Value By	USD 313.85 Million by 2035
Growth Rate	CAGR of 4.77% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : X-ray/Fluoroscopy Phantoms Ultrasound Phantoms CT Phantoms MRI Phantoms Nuclear Imaging Phantoms Others By Application : Hospitals Medical Device Companies Academic & Research Institutes Diagnostic & Reference Laboratories Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample